Sebastian Schäfer is a Co-founder of Enleofen Bio, a Singaporean biotech company developing first-in-class antibody therapeutics for the treatment of fibro-inflammatory diseases.
For speaking, sponsorship and exhibition opportunities contact
jonathan.mottram@terrapinn.com
Tel: +65 6322 2738